EUROTOX 2019 - 55th Congress of the European Societies of Toxicology

Sunday, 8 September, 2019 (All day) to Wednesday, 11 September, 2019 (All day)

The EUROTOX2019 Scientific Programme Committee, chaired by Prof. H. Wallace, has prepared an exciting scientific programme, highlighting the latest research results and trends in the field of toxicology.


  • Challenges of non-animal approaches for food safety: from inception to application
  • Knowledge-based computational approaches in predictive toxicology
  • Application of NAMs and development of IATAs-moving toward mechanistic risk assessment
  • Understanding the interindividual variability in toxicity involving the psychotropic drugs
  • Investigative Toxicology Leaders Forum (ITLF): Scientific advancements and case studies for the optimization of drug discovery. Trends in investigative toxicology
  • The process of ageing and its modulation: telomeres as biomarkers in in vitro and in vivo studies
  • Speeding up hazard assessment of nanomaterials
  • Fetus – the most sensitive individual
  • Experimental comprehensive toxicological studies simulating real-life exposures: long-term combined exposures on multi endpoints
  • Biomarkers in predictive toxicology and risk assessment
  • Endocrine Disruption: identification of root causes
  • Comprehensive toxicological profiles in nanoformulations for blood brain barrier
  • Advancing toxicological evaluations in resolving current policy controversies in GMO products
  • Neurotoxicity in the scientific and regulatory outlook
  • Toxic epidemics: why should we still be worried in 2019?
  • The Exposome – Understanding the role of environmental exposure in human health and disease
  • Detection, assessment, management and communication of risk in mass human toxic exposures
  • Metabolic capacity and functionality of the gut microbiome
  • Implications of biodistribution of inhaled nanoparticles: effects in organs other than the lung
  • Human adaptation to environmental pollution: dose-response relationship revisited
  • Developments in the use of systematic review in chemical risk assessment
  • Chemical risk assessment using human in vitro, ex vivo, in silico and biomonitoring data
  • New tools and application in reg. risk assessment – moving toward mechanistic risk assessment
  • Hepatotoxicity-mechanisms, new insight into liver function, and possibilities of in vitro prediction
  • Suitability of non-animal approaches in different industries: One size fits all?
  • How innate immune cells recognize toxicants – consequences for immune-mediated toxicity
  • Optimization of existing and construction of new testing strategies for skin sensitization potency
  • Investigative Toxicology Leaders Forum (ITLF): Scientific advancements and case studies for the optimization of drug discovery. DILI case studies
Helsinki, Finland